Section Arrow
RCUS.NYSE
- Arcus Biosciences
Quotes are at least 15-min delayed:2026/06/01 05:34 EDT
Pre Market
Last
 25.3562
+0.0162 (+0.06%)
Bid
25.35
Ask
25.95
High 25.3562 
Low 25.3562 
Volume
Regular Hours (Closed)
Last
 25.34
+0.86 (+3.51%)
Day High 
25.48 
Prev. Close
24.48 
1-M High
26.7 
Volume 
2.18M 
Bid
25.35
Ask
25.95
Day Low
24.13 
Open
24.45 
1-M Low
22.61 
Market Cap 
3.08B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 23.85 
20-SMA 24.63 
50-SMA 23.57 
52-W High 28.72 
52-W Low 7.91 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-3.17/-3.85
Enterprise Value
3.18B
Balance Sheet
Book Value Per Share
4.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
247.00M
Operating Revenue Per Share
0.95
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.1172-0.0468-28.54%-- 
Pre Market 0.082 -0.0352 -30.03%
REPLReplimune Group8.69+4.01+85.68%-- 
Pre Market 9.79 +1.1 +12.66%
CDTCDT Equity Inc.1.04+0.0899+9.46%-- 
Pre Market 0.95 -0.09 -8.65%
CMNDClearmind Medicine Inc.3.58+1.13+46.12%-- 
Pre Market 2.6795 -0.9005 -25.15%
OTLKOutlook Therapeutics0.73-0.01-1.35%-- 
Pre Market 0.6986 -0.0314 -4.30%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.